Item 2.02  Results of Operations and Financial Condition.
On August 7, 2020, Denali Therapeutics Inc. (the "Company") issued a press
release announcing its financial results for the second quarter ended June 30,
2020. The full text of the press release is attached hereto as Exhibit 99.1 and
is incorporated herein by reference.
All of the information furnished in this Item 2.02 and Item 9.01 (including
Exhibit 99.1) shall not be deemed to be "filed" for purposes of Section 18 of
the Securities Exchange Act of 1934, as amended, and shall not be incorporated
by reference in any filing under the Securities Act of 1933, as amended, or the
Securities Exchange Act of 1934, as amended, except as shall be expressly set
forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit No.       Description
99.1                Press Release dated August     7    , 2020  .
104               Cover Page Interactive Data File (formatted as Inline XBRL)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses